Protected: The VESL Wall Issue #13 is now out! This month we feature the new CCS guidelines on peripheral arterial disease and we bring you a cost-effectiveness analysis of inclisiran in the US healthcare system, and a statistical model to better predict familial hypercholesterolemia and improve the screening yield to enable earlier intervention July 3, 2022July 3, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: Blood Flow by VESL #9 is now out! Dr. Liam Brunham provides highlights from the 2022 European Atherosclerosis Society and National Lipid Association meetings. Watch the video here. June 17, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: The VESL Wall Issue #12 is now out! This month we feature a post-hoc analysis of the heart failure subset in the REDUCE-IT trial with icosapent ethyl, the Phase 2 dose-finding study of the antisense agent vupanorsen, and a new review on the role of Lp(a) in familial hypercholesterolemia. June 1, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: The VESL Wall Issue #11 is now out! This month’s issue features new publications on improving dietary modifications for the prevention of ASCVD, the use of plasma exchange to reduce triglyceride levels in patients with acute pancreatitis, and ASCVD prevalence and outcomes associated with Lp(a) levels in patients with familial hypercholesterolemia. May 9, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: Introducing the ASCVD & Lipidology Knowledge Hub from Wiley April 23, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: The VESL Wall Issue #10 is now out! This month’s issue is all about FH, with a retrospective cohort study characterizing HoFH patients, a look at the prevalence of HeFH across different global ethnicities, and a review of the role of Lp(a) in FH. April 7, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: Blood Flow by VESL #8 is now out! To recognize Lp(a) Awareness Day on March 24th, Drs. Brunham and Hegele discuss the importance of Lp(a) as a risk factor for ASCVD. Watch the video here. March 21, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: The VESL Wall Issue #9 is now out! We take a look at new triglyceride data with the antisense therapy olezarsen, a systematic review and meta-analysis of CV outcomes in patients with HoFH, and the association between adherence to the Portfolio cholesterol-reducing diet and mortality in a cohort of Chinese patients March 3, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: The VESL Wall Issue #8 is now out! In this issue, we feature an analysis of LDLR genotypes and lipid-lowering therapy, the association between different hypertensives and the risk of new onset diabetes, and hear a definitive call to elevate apoB measurements in routine clinical care. January 27, 2022June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
Protected: The VESL Wall Issue #7 is now out! In this issue, we feature publications on dyslipidemia in the modern era, expanding anti-PCSK9 therapy beyond cardiovascular disease, and outcomes across three different anti-PCSK9 therapies. December 9, 2021June 19, 2022 ~ veslcommunity This content is password protected. To view it please enter your password below: Password:
VESL 